Towards Healthcare
Parkinson's Disease Diagnosis and Treatment Market Surges USD 16.14 Bn by 2034

Parkinson's Disease Diagnosis and Treatment Market Fosters Innovative Medication Development

According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 6.88 billion in 2024, is anticipated to reach USD 16.14 billion by 2034, growing at a CAGR of 8.9% over the next decade. In 2023, medications led the Parkinson’s disease market with a 40% share, while North America dominated at 38%. Asia Pacific is set to grow fastest, with a 7.0% CAGR. Key players include Siemens Healthineers, Abbott, GE, AbbVie, Merck, Pfizer, Teva, Sun Pharma, Novartis, and Cerevel Therapeutics.

Last Updated : 22 December 2025 Category: Therapeutic Area Insight Code: 5142 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value chain analysis
    • Raw material sourcing
    • Manufacturing process
    • Logistics & transportation
    • Buyer preferences
  • Trends
    • Market trends
    • Technological trends
  • Porter’s Five Forces Analysis
    • Bargaining power of suppliers
    • Bargaining power of buyers
    • Threat of substitute
    • Threat of new entrants
    • Degree of competition
  • PESTLE Analysis for 5 leading countries
    • Regulatory framework for leading countries/regions
    • Supply demand analysis
    • Production & consumption statistics
    • Export Import statistics
    • Price trend analysis

Global Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Europe Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

South America Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Company Profiles

  • Siemens Healthineers AG
    • Company overview
    • Geographic footprints
    • Financial performance
    • Product portfolio
    • SWOT analysis
    • R&D efforts
    • Recent developments & strategic collaborations
      • Product launch/M&A/Technical collaboration
  • Abbott Laboratories
  • General Electric Company
  • AbbVie
  • Merck & Co.
  • Pfizer
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharma
  • Novartis AG
  • Cerevel Therapeutics

Conclusion & Recommendations

FAQ's

Answer : Symptoms of Parkinsons disease include tremors, stiffness, slow movement, and problems with balance and coordination.

Answer : North America leads the market for Parkinsons disease diagnosis and treatment.

Answer : Deep Brain Stimulation (DBS) is a surgical procedure where electrodes are implanted into specific areas of the brain. These electrodes deliver electrical impulses to regulate abnormal brain activity, helping to alleviate symptoms of movement disorders like Parkinsons disease.

Answer : Department of Health, State Government of Victoria, Australia, U.S. Department of Veterans Affairs, National Institute of Health, WHO
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar